"At Baptist Health in Jacksonville, FL, our mission is to continue the healing ministry of Christ by providing accessible, quality health care services at a reasonable cost in an atmosphere that fosters respect and compassion."

During the past decade, Baptist MD Anderson Cancer Center conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 82 clinical trials were completed, i.e. on average, 120.6% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 25 clinical trials were completed. i.e. 138.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baptist MD Anderson Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 49 trials, followed by "Radiation Therapy Oncology Group" with 30 trials sponsored, "Alliance for Clinical Trials in Oncology" with 21 trials sponsored, "NSABP Foundation Inc" with 18 trials sponsored and "Eastern Cooperative Oncology Group" with 18 trials sponsored. Other sponsors include 98 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baptist MD Anderson Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 106 trials as a collaborator, "NRG Oncology" with 33 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "Radiation Therapy Oncology Group" with 9 trials as a collaborator and "Canadian Cancer Trials Group" with 8 trials as a collaborator. Other collaborators include 88 different institutions and companies that were collaborators in the rest 63 trials.

According to Clinical.Site data, the most researched conditions in "Baptist MD Anderson Cancer Center" are "Breast Cancer" (29 trials), "Lung Cancer" (14 trials), "Brain and Central Nervous System Tumors" (8 trials), "Colorectal Cancer" (8 trials) and "Prostate Cancer" (7 trials). Many other conditions were trialed in "Baptist MD Anderson Cancer Center" in a lesser frequency.

Most popular intervention types in "Baptist MD Anderson Cancer Center" are "Drug" (178 trials), "Other" (73 trials), "Biological" (59 trials), "Radiation" (58 trials) and "Procedure" (34 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (34 trials), "Quality-of-Life Assessment" (24 trials), "Placebo" (19 trials), "Cisplatin" (18 trials) and "Paclitaxel" (15 trials). Other intervention names were less common.

The vast majority of trials in "Baptist MD Anderson Cancer Center" are 180 trials for "All" genders, 47 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Baptist MD Anderson Cancer Center". undefined are not yet recruiting, 35 are recruiting, 61 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 122 completed trials in Baptist MD Anderson Cancer Center, 1 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Baptist MD Anderson Cancer Center, 12 "Phase 1" clinical trials were conducted, 88 "Phase 2" clinical trials and 131 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".